Keyphrases
Pulmonary Hypertension
100%
Right Ventricle
100%
In Vitro Study
100%
Selexipag
100%
Left Ventricular End-diastolic Volume (LVEDV)
66%
Cardiac Magnetic Resonance Imaging (cMRI)
66%
Pulmonary Arterial Hypertension
66%
Right Ventricular Function
66%
Current Treatment
33%
Right Ventricular Mass
33%
Right Ventricular End-diastolic Volume
33%
Right Ventricular Ejection Fraction
33%
Lung
33%
Treatment Strategy
33%
Stroke Volume
33%
Treatment Therapy
33%
MRI Measurements
33%
Possible Treatments
33%
Ventricular Interaction
33%
Mass Volume
33%
Therapeutic Target
33%
Prognosis Prediction
33%
Left Ventricular Function
33%
Right Ventricular
33%
Vasoconstriction
33%
Medicine and Dentistry
Selexipag
100%
Right Ventricle
100%
In Vitro
100%
Pulmonary Hypertension
100%
Right Ventricular Function
40%
Cardiac Magnetic Resonance Imaging
40%
End-Diastolic Volume
20%
Stroke Volume
20%
Heart Left Ventricle Ejection Fraction
20%
Vasoconstriction
20%
Lung
20%